Literature DB >> 17433628

Reduced posterior nasal cavity volume: a gender-specific neurodevelopmental abnormality in schizophrenia.

Bruce I Turetsky1, Charles A Glass, Jaime Abbazia, Christian G Kohler, Raquel E Gur, Paul J Moberg.   

Abstract

OBJECTIVE: We previously reported that men with schizophrenia had reduced volumes of the posterior nasal cavity bilaterally. Since the nasal cavities develop in conjunction with both the palate and ventral forebrain, this could represent a simple marker of embryological dysmorphogenesis contributing to schizophrenia. The current study expands on this finding by examining a larger sample of both male and female patients and unaffected 1st-degree relatives, to determine the gender distribution of this abnormality and the extent to which it may be genetically mediated.
METHOD: A measurement of nasal volume and geometry was acquired by acoustic rhinometry for 85 schizophrenia patients, 25 unaffected 1st-degree relatives of schizophrenia probands and 66 healthy comparison subjects.
RESULTS: Male patients had smaller posterior nasal volumes than both male control subjects and male relatives. However, female patients did not differ from either female controls or female family members. Unaffected 1st-degree relatives did not differ from same-sex control subjects. These findings persisted after covarying for height and smoking history, and were unrelated to clinical symptomatology or antipsychotic medication usage.
CONCLUSION: Posterior nasal cavity volume decrement appears to be a specific developmental craniofacial abnormality that may reflect an early disruption in embryological development in males with schizophrenia. Although further study is needed, this may be a marker of a "second hit" that distinguishes genetically vulnerable men who go on to develop the illness from those who do not.

Entities:  

Mesh:

Year:  2007        PMID: 17433628      PMCID: PMC2692622          DOI: 10.1016/j.schres.2007.02.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  36 in total

1.  Problems with the Waldrop scale.

Authors:  M Trixler; T Tényi
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

2.  P300 subcomponent abnormalities in schizophrenia: III. Deficits In unaffected siblings of schizophrenic probands.

Authors:  B I Turetsky; T D Cannon; R E Gur
Journal:  Biol Psychiatry       Date:  2000-03-01       Impact factor: 13.382

3.  Consensus report on acoustic rhinometry and rhinomanometry.

Authors:  P A R Clement; F Gordts
Journal:  Rhinology       Date:  2005-09       Impact factor: 3.681

Review 4.  Olfactory dysfunction in schizophrenia: a qualitative and quantitative review.

Authors:  P J Moberg; R Agrin; R E Gur; R C Gur; B I Turetsky; R L Doty
Journal:  Neuropsychopharmacology       Date:  1999-09       Impact factor: 7.853

5.  The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins.

Authors:  A Lane; A Kinsella; P Murphy; M Byrne; J Keenan; K Colgan; B Cassidy; N Sheppard; R Horgan; J L Waddington; C Larkin; E O'Callaghan
Journal:  Psychol Med       Date:  1997-09       Impact factor: 7.723

6.  Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process.

Authors:  J L Waddington; A Lane; P Scully; D Meagher; J Quinn; C Larkin; E O'Callaghan
Journal:  J Psychiatr Res       Date:  1999 Nov-Dec       Impact factor: 4.791

Review 7.  The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease.

Authors:  J L Waddington; A Lane; C Larkin; E O'Callaghan
Journal:  Biol Psychiatry       Date:  1999-07-01       Impact factor: 13.382

8.  Minor physical anomalies in familial and sporadic schizophrenia: the Maudsley family study.

Authors:  T D Griffiths; T Sigmundsson; N Takei; S Frangou; P B Birkett; T Sharma; A M Reveley; R M Murray
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

9.  Smaller nasal volumes as stigmata of aberrant neurodevelopment in schizophrenia.

Authors:  Paul J Moberg; David R Roalf; Raquel E Gur; Bruce I Turetsky
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

Review 10.  Human prenatal craniofacial development related to brain development under normal and pathologic conditions.

Authors:  I Kjaer
Journal:  Acta Odontol Scand       Date:  1995-06       Impact factor: 2.331

View more
  7 in total

1.  Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.

Authors:  Vidyulata Kamath; Paul J Moberg; Raquel E Gur; Richard L Doty; Bruce I Turetsky
Journal:  Behav Neurosci       Date:  2011-12-12       Impact factor: 1.912

2.  An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis.

Authors:  Vidyulata Kamath; Paul J Moberg; Monica E Calkins; Karin Borgmann-Winter; Catherine G Conroy; Raquel E Gur; Christian G Kohler; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2012-04-25       Impact factor: 4.939

Review 3.  Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?

Authors:  Michael T Compton; Elaine F Walker
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

4.  Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia?

Authors:  Bruce I Turetsky; Patrick Crutchley; Jeffrey Walker; Raquel E Gur; Paul J Moberg
Journal:  Schizophr Res       Date:  2009-09-20       Impact factor: 4.939

Review 5.  Scents and nonsense: olfactory dysfunction in schizophrenia.

Authors:  Bruce I Turetsky; Chang-Gyu Hahn; Karin Borgmann-Winter; Paul J Moberg
Journal:  Schizophr Bull       Date:  2009-09-30       Impact factor: 9.306

6.  Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects.

Authors:  Bruce I Turetsky; Paul J Moberg; Megan Quarmley; Erich Dress; Monica E Calkins; Kosha Ruparel; Karthik Prabhakaran; Raquel E Gur; David R Roalf
Journal:  Schizophr Res       Date:  2017-09-30       Impact factor: 4.939

7.  Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.

Authors:  Emilio Sacchetti; Catia Scassellati; Alessandra Minelli; Paolo Valsecchi; Cristian Bonvicini; Patrizio Pasqualetti; Alessandro Galluzzo; Rosaria Pioli; Massimo Gennarelli
Journal:  BMC Med Genet       Date:  2013-03-09       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.